{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:39:59Z","timestamp":1787625599170,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01052-2","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:58:40Z","timestamp":1753120720000},"page":"619-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH registry"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5164-7435","authenticated-orcid":false,"given":"Christina","family":"Antza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos V.","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Liamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Skoumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukianos","family":"Rallidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Garoufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sfikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genovefa","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Penopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Skalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-8044","authenticated-orcid":false,"given":"Michalis","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Anagnostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0692-5477","authenticated-orcid":false,"given":"Evgenia","family":"Mavrokefalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Boufidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermioni","family":"Petkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-3558","authenticated-orcid":false,"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-4493","authenticated-orcid":false,"given":"Ioanna","family":"Dima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6178-4868","authenticated-orcid":false,"given":"Georgios","family":"Fakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-2615","authenticated-orcid":false,"given":"Konstantinos A.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-9994","authenticated-orcid":false,"given":"Achilleas","family":"Attilakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Koumaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vana","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Agapakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Zacharis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Moustou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-2644","authenticated-orcid":false,"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Kountouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Mpellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Prodromiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"1052_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/s0140-6736(21)01122-3","volume":"398","author":"EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","year":"2021","unstructured":"EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021;398:1713\u201325. https:\/\/doi.org\/10.1016\/s0140-6736(21)01122-3","journal-title":"Lancet"},{"key":"1052_CR2","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/hjh.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071. https:\/\/doi.org\/10.1097\/hjh.0000000000003480","journal-title":"J Hypertens"},{"key":"1052_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/hypertensionaha.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285\u201392. https:\/\/doi.org\/10.1161\/hypertensionaha.119.14240","journal-title":"Hypertension"},{"key":"1052_CR4","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.2174\/1381612823666170328142433","volume":"23","author":"V Kotsis","year":"2017","unstructured":"Kotsis V, Antza C, Doundoulakis I, Stabouli S. Markers of early vascular ageing. Curr Pharm Des. 2017;23:3200\u20134. https:\/\/doi.org\/10.2174\/1381612823666170328142433","journal-title":"Curr Pharm Des"},{"key":"1052_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","volume":"201","author":"DC Chan","year":"2015","unstructured":"Chan DC, Pang J, Hooper AJ, Burnett JR, Bell DA, Bates TR, et al. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Int J Cardiol. 2015;201:633\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.146","journal-title":"Int J Cardiol"},{"key":"1052_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"1052_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14310\/horm.2002.1749","volume":"16","author":"CV Rizos","year":"2017","unstructured":"Rizos CV, Athyros V, Bilianou E, Chrousos G, Garoufi A, Kolovou G, et al. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Hormones (Athens). 2017;16:200\u20134. https:\/\/doi.org\/10.14310\/horm.2002.1749","journal-title":"Hormones (Athens)"},{"key":"1052_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","volume":"102","author":"F Civeira","year":"2008","unstructured":"Civeira F, Ros E, Jarauta E, Plana N, Zambon D, Puzo J, et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol. 2008;102:1187\u201393. https:\/\/doi.org\/10.1016\/j.amjcard.2008.06.056.","journal-title":"Am J Cardiol"},{"key":"1052_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies","year":"2019","unstructured":"Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.014","journal-title":"Atherosclerosis"},{"key":"1052_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/HJH.0000000000002714","volume":"39","author":"GS Stergiou","year":"2021","unstructured":"Stergiou GS, Menti A, Kalpourtzi N, Gavana M, Vantarakis A, Chlouverakis G, et al. Prevalence, awareness, treatment and control of hypertension in Greece: EMENO national epidemiological study. J Hypertens. 2021;39:1034\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000002714","journal-title":"J Hypertens"},{"key":"1052_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/jcdd11120411","volume":"11","author":"G Kolovou","year":"2024","unstructured":"Kolovou G, Makrygiannis S, Marvaki C, Pavlatou N, Anagnostopoulou K, Giannakopoulou V, et al. Prevalence and risk factors for atherosclerotic cardiovascular disease in 7704 individuals: an analysis from the greek registry for the prevalence of familial hypercholesterolemia (GRegistry-FH). J Cardiovasc Dev Dis. 2024;11:411. https:\/\/doi.org\/10.3390\/jcdd11120411","journal-title":"J Cardiovasc Dev Dis"},{"key":"1052_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","volume":"135","author":"L Perez de Isla","year":"2017","unstructured":"Perez de Isla L, Alonso R, Mata N, Fernandez-Perez C, Muniz O, Diaz-Diaz JL, et al. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study). Circulation. 2017;135:2133\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024541","journal-title":"Circulation"},{"key":"1052_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","volume":"9","author":"EM deGoma","year":"2016","unstructured":"deGoma EM, Ahmad ZS, O\u2019Brien EC, Kindt I, Shrader P, Newman CB, et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry. Circ Cardiovasc Genet. 2016;9:240\u20139. https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001381","journal-title":"Circ Cardiovasc Genet"},{"key":"1052_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.05.040","volume":"277","author":"LR Brunham","year":"2018","unstructured":"Brunham LR, Ruel I, Khoury E, Hegele RA, Couture P, Bergeron J, et al. Familial hypercholesterolemia in Canada: initial results from the FH Canada national registry. Atherosclerosis. 2018;277:419\u201324. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.040","journal-title":"Atherosclerosis"},{"key":"1052_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101109","volume":"48","author":"G Vaseghi","year":"2023","unstructured":"Vaseghi G, Javanmard SH, Heshmat-Ghahdarijani K, Sarrafzadegan N, Amerizadeh A. Comorbidities with familial hypercholesterolemia (FH): a systematic review. Curr Probl Cardiol. 2023;48:101109. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101109","journal-title":"Curr Probl Cardiol"},{"key":"1052_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/eurheartj\/ehae791","volume":"46","author":"A Elshorbagy","year":"2025","unstructured":"Elshorbagy A, Vallejo-Vaz AJ, Barkas F, Lyons ARM, Stevens CAT, Dharmayat KI, et al. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry. Eur Heart J. 2025;46:1127\u201340. https:\/\/doi.org\/10.1093\/eurheartj\/ehae791","journal-title":"Eur Heart J"},{"key":"1052_CR17","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1016\/j.jacl.2024.01.005","volume":"18","author":"F Barkas","year":"2024","unstructured":"Barkas F, Rizos CV, Liamis G, Skoumas I, Garoufi A, Rallidis L, et al. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: an analysis from HELLAS-FH registry. J Clin Lipidol. 2024;18:e394\u2013e402. https:\/\/doi.org\/10.1016\/j.jacl.2024.01.005","journal-title":"J Clin Lipidol"},{"key":"1052_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/ars.2023.0284","volume":"40","author":"AL Gonzalez","year":"2024","unstructured":"Gonzalez AL, Dungan MM, Smart CD, Madhur MS, Doran AC. Inflammation resolution in the cardiovascular system: arterial hypertension, atherosclerosis, and ischemic heart disease. Antioxid Redox Signal. 2024;40:292\u2013316. https:\/\/doi.org\/10.1089\/ars.2023.0284","journal-title":"Antioxid Redox Signal"},{"key":"1052_CR19","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.3390\/ijms25137295","volume":"25","author":"E M\u0142ynarska","year":"2024","unstructured":"M\u0142ynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, et al. From atherosclerotic plaque to myocardial infarction\u2014the leading cause of coronary artery occlusion. Int J Mol Sci. 2024;25:7295.","journal-title":"Int J Mol Sci"},{"key":"1052_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1573402115666190415161813","volume":"16","author":"A Katsimardou","year":"2020","unstructured":"Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Hypertension in metabolic syndrome: novel insights. Curr Hypertens Rev. 2020;16:12\u201318. https:\/\/doi.org\/10.2174\/1573402115666190415161813","journal-title":"Curr Hypertens Rev"},{"key":"1052_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40256-015-0128-1","volume":"15","author":"B Ivanovic","year":"2015","unstructured":"Ivanovic B, Tadic M. Hypercholesterolemia and hypertension: two sides of the same coin. Am J Cardiovasc Drugs. 2015;15:403\u201314. https:\/\/doi.org\/10.1007\/s40256-015-0128-1","journal-title":"Am J Cardiovasc Drugs"},{"key":"1052_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","volume":"256","author":"AC Jansen","year":"2004","unstructured":"Jansen AC, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med. 2004;256:482\u201390. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01405.x","journal-title":"J Intern Med"},{"key":"1052_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2796.2003.01070.x","volume":"253","author":"PR de Sauvage Nolting","year":"2003","unstructured":"de Sauvage Nolting PR, Defesche JC, Buirma RJ, Hutten BA, Lansberg PJ, Kastelein JJ. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. J Intern Med. 2003;253:161\u20138. https:\/\/doi.org\/10.1046\/j.1365-2796.2003.01070.x","journal-title":"J Intern Med"},{"key":"1052_CR24","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1097\/HJH.0000000000003204","volume":"40","author":"MM Liu","year":"2022","unstructured":"Liu MM, Peng J, Xu RX, Guo YL, Zhu CG, Wu NQ, et al. Hypertension and clinical outcomes in patients with familial hypercholesterolemia. J Hypertens. 2022;40:1713\u201321. https:\/\/doi.org\/10.1097\/HJH.0000000000003204","journal-title":"J Hypertens"},{"key":"1052_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacl.2018.10.012","volume":"13","author":"LE Akioyamen","year":"2019","unstructured":"Akioyamen LE, Genest J, Chu A, Inibhunu H, Ko DT, Tu JV. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. J Clin Lipidol. 2019;13:15\u201330. https:\/\/doi.org\/10.1016\/j.jacl.2018.10.012","journal-title":"J Clin Lipidol"},{"key":"1052_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/biomedicines12010231","volume":"12","author":"C Antza","year":"2024","unstructured":"Antza C, Rizos CV, Kotsis V, Liamis G, Skoumas I, Rallidis L, et al. Familial hypercholesterolemia in the elderly: an analysis of clinical profile and atherosclerotic cardiovascular disease burden from the Hellas-FH registry. Biomedicines. 2024;12:231. https:\/\/doi.org\/10.3390\/biomedicines12010231","journal-title":"Biomedicines"},{"key":"1052_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-015-0042-6","volume":"8","author":"TM Alhawassi","year":"2015","unstructured":"Alhawassi TM, Krass I, Pont LG. Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review. J Pharm Policy Pract. 2015;8:24. https:\/\/doi.org\/10.1186\/s40545-015-0042-6","journal-title":"J Pharm Policy Pract"},{"key":"1052_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","volume":"11","author":"M Paquette","year":"2017","unstructured":"Paquette M, Dufour R, Baass A. The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia. J Clin Lipidol. 2017;11:80\u201386. https:\/\/doi.org\/10.1016\/j.jacl.2016.10.004","journal-title":"J Clin Lipidol"},{"key":"1052_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2024.09.021","volume":"233","author":"H Tada","year":"2024","unstructured":"Tada H, Kojima N, Takeji Y, Nohara A, Kawashiri MA, Takamura M. Impact of blood pressure management on cardiovascular events in patients with familial hypercholesterolemia. Am J Cardiol. 2024;233:1\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2024.09.021","journal-title":"Am J Cardiol"},{"key":"1052_CR30","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). European Heart Journal. 2024;45:3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178","journal-title":"European Heart Journal"},{"key":"1052_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.mcna.2009.02.006","volume":"93","author":"WB Kannel","year":"2009","unstructured":"Kannel WB. Hypertension: reflections on risks and prognostication. Med Clin North Am. 2009;93:541\u201358. https:\/\/doi.org\/10.1016\/j.mcna.2009.02.006.","journal-title":"Med Clin North Am"},{"key":"1052_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00895-2","volume":"11","author":"II Chan","year":"2021","unstructured":"Chan II, Kwok MK, Schooling CM. The total and direct effects of systolic and diastolic blood pressure on cardiovascular disease and longevity using Mendelian randomisation. Sci Rep. 2021;11:21799. https:\/\/doi.org\/10.1038\/s41598-021-00895-2","journal-title":"Sci Rep"},{"key":"1052_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Collaboration NCDRF","year":"2021","unstructured":"Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1","journal-title":"Lancet"},{"key":"1052_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.33963\/v.kp.97845","volume":"81","author":"P Anagnostis","year":"2023","unstructured":"Anagnostis P, Antza C, Florentin M, Kotsis V. Familial hypercholesterolemia and its manifestations: practical considerations for general practitioners. Kardiol Pol. 2023;81:1081\u20138. https:\/\/doi.org\/10.33963\/v.kp.97845","journal-title":"Kardiol Pol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01052-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01052-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01052-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:05:36Z","timestamp":1757498736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01052-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01052-2","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CA, CVR, GL, AG, GS, PA, VK, GA, EP, ID, FG, KAP, AA, VK, CK, DA, CB, EM, AP have nothing to declare. IS has given talks, received honoraria, and participated in clinical trials sponsored by MSD, AMGEN, SANOFI. LR has received research grants and honoraria from Amgen, Sanofi-Aventis, Viatris, Novartis, Vianex and Servier. GK has given talks, attended conferences and participated in trials sponsored by Amgen, Angelini, MSD, Lilly, Vianex and Sanofi and has also accepted travel support to conferences from Amgen, Sanofi and MSD. ES has participated in educational and advisory activities sponsored by AstraZeneca, Medtronic, MSD, Sanofi and Servier. VK has given talks and attended conferences sponsored by AstraZeneca, MSD, Sanofi-Aventis, and Vianex. MD has given lectures for and participated in trials sponsored by Novo-Nordisc, Astra-Zeneca, Novartis, Eli-Lilly, Menarini, WinMedica, Innovis, Boehringer, Elpen, Viatris KS has received honoraria from Amgen. VL has given lectures, attended conferences and participated in trials sponsored by Novo Nordisk, Sanofi-Aventis, Novartis, AstraZeneca, Boehringer-Ingelheim, MSD, GSK, Vianex, Elli Lilly, ELPEN, Mylan and Aegereon. AB has received honoraria from Vianex, Amarin and Sanofi. EL has participated in educational, research and advisory activities sponsored by AstraZeneca, MSD, Lilly, Bayer, Amgen, Sanofi, Boehringer-Ingelheim, Novartis, Novo Nordisk, Valeant and Servier. EZ has received honoraria for lectures from Amgen. Sanofi, MSD, and Astra Zeneca. CV has received research grants and fees for scientific activities from Amgen, AstraZeneca, Boehringer-Ingelheim, ELPEN, Mylan, Novartis, Sanofi, MSD, and Vianex. HM participated in educational, research and consulting activities supported by healthcare companies, including Amgen, AstraZeneca, Boehringer Ingelheim, Elpen, Novartis, Sanofi, Vianex, Ultragenyx, Winmedica. ENL has participated in educational, research and advisory activities sponsored by AstraZeneca, MSD, Lilly, Bayer, Amgen, Sanofi, Boehringer Ingelheim, Novartis, Novo Nordisk, Valeant and Servier.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by all institutions\u2019 scientific and ethics committees and the Hellenic Data Protection Authority. All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants prior to inclusion in the registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}